Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| KalVista Pharmaceuticals, Inc. | 150,260 | reported | 26 May 2026 | tx 117+802,367−381,590 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 26 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 2,239 | 26.78 USD | |
| 22 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 22 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 2,685 | 26.78 USD | |
| 21 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 17 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | — | |
| 18 May 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,032 | 26.76 USD | |
| 17 May 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | 0.00 USD | deriv |
| 16 Apr 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 17 Apr 2026 | SALE | KalVista Pharmaceuticals, Inc. | 2,686 | 20.22 USD | |
| 16 Apr 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 23 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 5,354 | 15.57 USD | |
| 22 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 22 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |
| 21 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | 0.00 USD | deriv |
| 18 Feb 2026 | SALE | KalVista Pharmaceuticals, Inc. | 1,163 | 15.00 USD | |
| 17 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | — | |
| 17 Feb 2026 | EXERCISE | KalVista Pharmaceuticals, Inc. | 2,419 | 0.00 USD | deriv |
| 16 Jan 2026 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 21 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 6,250 | — | |
| 24 Nov 2025 | SALE | KalVista Pharmaceuticals, Inc. | 5,296 | 13.45 USD | |
| 22 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | — | |
| 22 Nov 2025 | EXERCISE | KalVista Pharmaceuticals, Inc. | 5,000 | 0.00 USD | deriv |